Maurizio Zazzi

38PUBLICATIONS
133CO-AUTHORS
Disease surveillanceMedical molecular engineering of nucleic acids and proteinsGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)Genomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|May 13, 2026
HIV-1 Sub-subtype A6 Remains Susceptible to Second-Generation Integrase Inhibitors With Limited Emergence of Resistance in Vitro.

|Feb 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes.

Laura Pezzati, Federico Conti, William Gennari

|Sep 24, 2025
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry.

D Armenia, G Marchegiani, V Spagnuolo

|Aug 28, 2025
Correction: Biba et al. A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations. Viruses 2024, 16, 1465.

Camilla Biba, Lia Fiaschi, Ilenia Varasi

|Jun 27, 2025
Time fixes everything, but not always: 10 years of persistent PI mutations in the absence of pharmacological pressure-a case report.

Layla Pagnucco, Antonella Castagna, Maria Mercedes Santoro

|May 27, 2025
HIV multidrug class resistance prediction with a time sliding anchor approach.

Nurhan Arslan, Ralf Eggeling, Bernhard Reuter

Pageof 7

Frequent Collaborators

21 joint publications

Ilaria Vicenti

7 joint publications

Filippo Dragoni

6 joint publications

Francesco Saladini

5 joint publications

Federica Giammarino